| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/10/2004 | WO2002098890A3 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/10/2004 | WO2002097053A3 Small molecule antagonists of bcl2 family proteins |
| 09/10/2004 | WO2002094780A3 Kinases and phosphatases |
| 09/10/2004 | WO2002092840A3 Agents that regulate apoptosis |
| 09/10/2004 | CA2555746A1 Use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea for the treatment of pancreatic cancer, soft-tissue sarcoma, testicular tumors, lymphoma, thymoma, wilm's tumors, renal carcinoma, melanoma, lung cancer, intracerebral metastasis, tumors in the head and neck region, and mammary carcinoma |
| 09/10/2004 | CA2517416A1 Therapeutic compositions |
| 09/10/2004 | CA2517285A1 Transcriptional factor inducing apoptosis in cancer cell |
| 09/10/2004 | CA2516900A1 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/10/2004 | CA2516842A1 Hydroxamic acid compounds comprising a bicylic heteroaryl group as hdac inhibitors |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | CA2516399A1 Pharmaceutical compositions of safingol and methods of using the same |
| 09/10/2004 | CA2516239A1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 09/10/2004 | CA2515389A1 Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical compostion, and diagnostic reagent |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040176625 Kinesin motor modulators derived from the marine sponge Adocia |
| 09/09/2004 | US20040176605 Compounds as antumor agents or immunosuppressants |
| 09/09/2004 | US20040176601 Benzimisazo[4,5-f]isoquinolinone derivatives |
| 09/09/2004 | US20040176594 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 09/09/2004 | US20040176576 Antibodies against cancer |
| 09/09/2004 | US20040176573 Major histocompatibility complex class I restricted epitope peptide for use in diagnosis, prevention and treament of cell proliferative disorders; antitumor agents |
| 09/09/2004 | US20040176571 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176458 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/09/2004 | US20040176456 Method of treatment for sexual dysfunction |
| 09/09/2004 | US20040176439 coadministration of agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), and an oral bioavailability-enhancing agent (e.g., cyclosporin A, cyclosporin D, cyclosporin F) |
| 09/09/2004 | US20040176436 Tryptophanyl-esters and their N-acyl derivatives for preventing and treating diseases caused or aggravated by oxidation processes |
| 09/09/2004 | US20040176431 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176426 farnesoid X receptor; to mitigate and thereby treat hypercholesterolemia; antagonists, which block the negative feedback downregulation of cyp7a expression produced by certain cholic acids |
| 09/09/2004 | US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
| 09/09/2004 | US20040176418 protease activated receptor (PAR) antagonists will be useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders |
| 09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176405 Methods and compounds for inhibitting MRP1 |
| 09/09/2004 | US20040176394 Administering heterocyclic esters such as 5-(2,4-Dimethyl-phenyl)-3-(8-hydroxy-quinolin-2-ylamino)-5-methyl-dihydro-furan-2-one for prophylaxis of headaches, sepsis, neurodegenerative diseases, or as analgesics, antiischemic or antidiabetic agents |
| 09/09/2004 | US20040176390 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176386 Compounds |
| 09/09/2004 | US20040176385 treating cancer by inhibiting phosphotidylinositol 3-kinase; in combination with other known agents to modulate cellular proliferation |
| 09/09/2004 | US20040176384 inhibit Tissue factor expression and vascular permeability factor expression in cancer cells and in vascular endothelial cells in the tumor microenvironment; low toxicity to normal vascular endothelial cells |
| 09/09/2004 | US20040176380 Antiproliferative agents; specific cell cycle kinases inhibitors |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176367 1-Amino 1H-imidazoquinolines |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
| 09/09/2004 | US20040176362 Matrix metalloproteinase inhibitors, treatment of tumor necrosis factor mediated diseases; autoimmune and neurodegenerative disorders; anticarcinogenic and antiinflammatory agents |
| 09/09/2004 | US20040176346 Cytostatic lanthanum compounds |
| 09/09/2004 | US20040176339 Antineoplastic combinations |
| 09/09/2004 | US20040176332 Phosphoramide compounds |
| 09/09/2004 | US20040176327 Use of bisphosphonic acids for treating angiogenesis |
| 09/09/2004 | US20040176326 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176320 Use of at least one glycoinhibitor substance |
| 09/09/2004 | US20040176310 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 09/09/2004 | US20040176309 Siglec inhibitors |
| 09/09/2004 | US20040176302 Methods for inhibiting tumor cell proliferation |
| 09/09/2004 | US20040176297 Characterizing and predicting responses; identifying most efficient, cost effective and/or convenient treatment regimens; computer profiling |
| 09/09/2004 | US20040176286 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/09/2004 | US20040176285 Tip39 polypeptides |
| 09/09/2004 | US20040176284 1,2-Dithio-5,8,11,14,17-pentaazocycloeicosane derivatives |
| 09/09/2004 | US20040176274 Analgesic methods using endothelin receptor ligands |
| 09/09/2004 | US20040176270 Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| 09/09/2004 | US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 09/09/2004 | US20040175825 for drug screening/diagnostics for inflammation, arthritis and cancer; genetic engineering; kits |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175774 Method for predicting the sensitivity to chemotherapy |
| 09/09/2004 | US20040175773 Screening method based on siah-numb interaction |
| 09/09/2004 | US20040175748 Using alterations in cyclin dependent kinase activity to identify modulators which inhibit or potentiate cellular senescence; antiaging/anticancer agents; enzyme inhibitors |
| 09/09/2004 | US20040175714 Human protooncogene kg-20 and protein encoded therein |
| 09/09/2004 | US20040175703 to be administered by inhalation, infusion, injection, or orally relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference in vitro and in vivo; genetic engineering |
| 09/09/2004 | US20040175448 Pharmaceutical compositions |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175402 Formulation |
| 09/09/2004 | US20040175399 Treating hyperplasic, hypertonic, cystic and/or neoplastic uterine gland tissue by local administration of a botulinum toxin or Clostridual neurotoxin |
| 09/09/2004 | US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine |
| 09/09/2004 | US20040175375 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 09/09/2004 | US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175361 Modulator of desmosomal cadherin-mediated cell adhesion using a Trp(tryptophan)-containing cell adhesion recognition sequence; anticarcinogenic, antitumor, and antimetastasis agents |
| 09/09/2004 | DE10307103A1 Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate Antitumor effective 2-substituted D-Homostra-1,3,5 (10) -triene-3-yl sulfamates |
| 09/09/2004 | DE10107663B4 Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung Testosterone-containing transdermal therapeutic system, process for its preparation and its use |
| 09/08/2004 | EP1454982A1 Mtehod of analyzing gene expression |
| 09/08/2004 | EP1454917A2 Diabody-type bispecific antibody |
| 09/08/2004 | EP1454914A1 Tumor antigen |
| 09/08/2004 | EP1454910A1 Substituted pyrimidinyl-2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 09/08/2004 | EP1454907A1 Quninazoline and pyridopyrmidine derivatives |
| 09/08/2004 | EP1454903A1 Thiadiazoline derivative |
| 09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1454893A1 Illudin analogs useful as antitumor agents |
| 09/08/2004 | EP1454890A2 Anti-tumor Acylfulvenes |
| 09/08/2004 | EP1454628A2 Medical use of p38/JTV-1 |
| 09/08/2004 | EP1454626A1 Method of inducing apoptosis and compositions therefor |
| 09/08/2004 | EP1454145A2 Method for the assessment and prognosis of sarcoidosis |
| 09/08/2004 | EP1454138A2 Immunocytokines with modulated selectivity |
| 09/08/2004 | EP1454137A2 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 09/08/2004 | EP1454136A2 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 09/08/2004 | EP1453977A2 Molecular characteristics of non-small cell lung cancer |
| 09/08/2004 | EP1453962A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |